107 Results
Position Statement on the Impact of Cannabis on Children and Adolescents
Position Statement on the Impact of Cannabis on Children and Adolescents
Position Statement In Opposition to Cannabis as Medicine
Position Statement In Opposition to Cannabis as Medicine
Position Statement on Discharge from Hospital-Based Care to the Community for Substance Use Disorders
Position Statement on Discharge from Hospital-Based Care to the Community for Substance Use Disorders
Position Statement on Treatment of Substance Use Disorders in the Criminal Justice System
Position Statement on Treatment of Substance Use Disorders in the Criminal Justice System
Position Statement on the Use of Antipsychotic Medication in Patients with Major Neurocognitive Disorder
Position Statement on the Use of Antipsychotic Medication in Patients with Major Neurocognitive Disorder
Position Statement on Recognition and Management of Substance Use Disorders and Other Mental Illnesses Comorbid with HIV
Position Statement on Recognition and Management of Substance Use Disorders and Other Mental Illnesses Comorbid with HIV
Need to Monitor and Assess the Public Health and Safety Consequences of Legalizing Marijuana
Resource Document on the Need to Monitor and Assess the Public Health and Safety Consequences of Legalizing Marijuana
Position Statement on Need to Monitor Public Health Consequences of Legalizing Cannabis
Position Statement on Need to Monitor Public Health Consequences of Legalizing Cannabis
Position Statement on Physician Health Programs in the Treatment of Addiction and Substance Use Disorders
Position Statement on Physician Health Programs in the Treatment of Addiction and Substance Use Disorders
Marijuana as Medicine
The medical use of marijuana has received considerable attention as several states have voted to remove civil and criminal penalties for patients with qualifying conditions. Yet, on a national level, marijuana remains a schedule I substance under the Controlled Substances Act (CSA), the most restrictive schedule enforced by the Drug Enforcement Administration (DEA) (1). The Food and Drug Administration (FDA), responsible for approving treatments after appropriate and rigorous study, addit
Position Statement on Pharmaceutical Marketing to Justice Entities regarding Medication Treatment for Substance Use Disorders
Position Statement on Pharmaceutical Marketing to Justice Entities regarding Medication Treatment for Substance Use Disorders
Position Statement on Assuring the Appropriate Care of Pregnant and Newly Delivered Women with Substance Use Disorders
Position Statement on Assuring the Appropriate Care of Pregnant and Newly Delivered Women with Substance Use Disorders